Literature DB >> 26996964

Computationally Designed Bispecific Antibodies using Negative State Repertoires.

Andrew Leaver-Fay1, Karen J Froning2, Shane Atwell2, Hector Aldaz2, Anna Pustilnik2, Frances Lu2, Flora Huang2, Richard Yuan2, Saleema Hassanali2, Aaron K Chamberlain2, Jonathan R Fitchett2, Stephen J Demarest3, Brian Kuhlman4.   

Abstract

A challenge in the structure-based design of specificity is modeling the negative states, i.e., the complexes that you do not want to form. This is a difficult problem because mutations predicted to destabilize the negative state might be accommodated by small conformational rearrangements. To overcome this challenge, we employ an iterative strategy that cycles between sequence design and protein docking in order to build up an ensemble of alternative negative state conformations for use in specificity prediction. We have applied our technique to the design of heterodimeric CH3 interfaces in the Fc region of antibodies. Combining computationally and rationally designed mutations produced unique designs with heterodimer purities greater than 90%. Asymmetric Fc crystallization was able to resolve the interface mutations; the heterodimer structures confirmed that the interfaces formed as designed. With these CH3 mutations, and those made at the heavy-/light-chain interface, we demonstrate one-step synthesis of four fully IgG-bispecific antibodies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26996964      PMCID: PMC4866497          DOI: 10.1016/j.str.2016.02.013

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  55 in total

1.  Protein design is NP-hard.

Authors:  Niles A Pierce; Erik Winfree
Journal:  Protein Eng       Date:  2002-10

2.  Algorithm discovery by protein folding game players.

Authors:  Firas Khatib; Seth Cooper; Michael D Tyka; Kefan Xu; Ilya Makedon; Zoran Popovic; David Baker; Foldit Players
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.

Authors:  Thomas Spreter Von Kreudenstein; Eric Escobar-Carbrera; Paula I Lario; Igor D'Angelo; Karine Brault; John Kelly; Yves Durocher; Jason Baardsnes; R Jeremy Woods; Michael Hongwei Xie; Pierre-Alain Girod; Michael D L Suits; Martin J Boulanger; David K Y Poon; Gordon Y K Ng; Surjit B Dixit
Journal:  MAbs       Date:  2013-07-08       Impact factor: 5.857

Review 4.  The new face of bispecific antibodies: targeting cancer and much more.

Authors:  Lawrence G Lum; Pamela A Davol; Randall J Lee
Journal:  Exp Hematol       Date:  2006-01       Impact factor: 3.084

5.  Design of multispecific protein sequences using probabilistic graphical modeling.

Authors:  Menachem Fromer; Chen Yanover; Michal Linial
Journal:  Proteins       Date:  2010-02-15

6.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.

Authors:  J B Ridgway; L G Presta; P Carter
Journal:  Protein Eng       Date:  1996-07

7.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

8.  A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism.

Authors:  Zhi Liu; Esther C Leng; Kannan Gunasekaran; Martin Pentony; Min Shen; Monique Howard; Janelle Stoops; Kathy Manchulenko; Vladimir Razinkov; Hua Liu; William Fanslow; Zhonghua Hu; Nancy Sun; Haruki Hasegawa; Rutilio Clark; Ian N Foltz; Wei Yan
Journal:  J Biol Chem       Date:  2015-01-12       Impact factor: 5.157

9.  Improving target cell specificity using a novel monovalent bispecific IgG design.

Authors:  Yariv Mazor; Vaheh Oganesyan; Chunning Yang; Anna Hansen; Jihong Wang; Hongji Liu; Kris Sachsenmeier; Marcia Carlson; Dhanesh V Gadre; Martin Jack Borrok; Xiang-Qing Yu; William Dall'Acqua; Herren Wu; Partha Sarathi Chowdhury
Journal:  MAbs       Date:  2015       Impact factor: 5.857

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  21 in total

Review 1.  Designing protein structures and complexes with the molecular modeling program Rosetta.

Authors:  Brian Kuhlman
Journal:  J Biol Chem       Date:  2019-11-07       Impact factor: 5.157

2.  A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1.

Authors:  Camilla De Nardis; Linda J A Hendriks; Emilie Poirier; Tudor Arvinte; Piet Gros; Alexander B H Bakker; John de Kruif
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

Review 3.  Computational design and experimental optimization of protein binders with prospects for biomedical applications.

Authors:  Alessandro Bonadio; Julia M Shifman
Journal:  Protein Eng Des Sel       Date:  2021-02-15       Impact factor: 1.952

4.  Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.

Authors:  K J Froning; A Leaver-Fay; X Wu; S Phan; L Gao; F Huang; A Pustilnik; M Bacica; K Houlihan; Q Chai; J R Fitchett; J Hendle; B Kuhlman; S J Demarest
Journal:  Protein Sci       Date:  2017-07-31       Impact factor: 6.725

Review 5.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03

6.  Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.

Authors:  Clara T Schoeder; Samuel Schmitz; Jared Adolf-Bryfogle; Alexander M Sevy; Jessica A Finn; Marion F Sauer; Nina G Bozhanova; Benjamin K Mueller; Amandeep K Sangha; Jaume Bonet; Jonathan H Sheehan; Georg Kuenze; Brennica Marlow; Shannon T Smith; Hope Woods; Brian J Bender; Cristina E Martina; Diego Del Alamo; Pranav Kodali; Alican Gulsevin; William R Schief; Bruno E Correia; James E Crowe; Jens Meiler; Rocco Moretti
Journal:  Biochemistry       Date:  2021-03-11       Impact factor: 3.162

Review 7.  Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins.

Authors:  Ji-Hee Ha; Jung-Eun Kim; Yong-Sung Kim
Journal:  Front Immunol       Date:  2016-10-06       Impact factor: 7.561

Review 8.  The making of bispecific antibodies.

Authors:  Ulrich Brinkmann; Roland E Kontermann
Journal:  MAbs       Date:  2017 Feb/Mar       Impact factor: 5.857

Review 9.  Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds.

Authors:  Hongyan Liu; Abhishek Saxena; Sachdev S Sidhu; Donghui Wu
Journal:  Front Immunol       Date:  2017-01-26       Impact factor: 7.561

10.  Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies.

Authors:  Mathilde Poussin; Arlene Sereno; Xiufeng Wu; Flora Huang; Jason Manro; Shanshan Cao; Carmine Carpenito; Andrew Glasebrook; Daniel J Powell; Stephen Demarest
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.